Both in Biotechnology
Palisade Bio vs Fate Therapeutics
Over the past year PALI returned −44.0% and FATE returned +59.5%; their daily moves had a correlation of 0.14.
PALI −44.0% FATE +59.5%Growth of $1, one year, split-adjusted
| Metric | PALI | FATE |
|---|---|---|
| Price | $1.12 | $2.01 |
| Market cap | $195.2M | $240.8M |
| Today | −3.45% | −3.37% |
| 1 month | −22.2% | −13.4% |
| 6 months | −47.4% | +11.7% |
| Year to date | −52.3% | +104.6% |
| 1 year | −42.3% | +55.8% |
| Revenue growth (YoY) | — | +9.2% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −2114.8% | −1448.6% |
| P/E (TTM) | — | — |
| Price / sales | 390.4× | 37.1× |
| Net cash | $125.2M | $153.8M |
| Dividend yield | — | — |
| Volatility (60d) | 75.4% | 56.0% |
| Short % of float | 18.3% | 10.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).